Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,998,002
-
Share change
-
+4,723,485
-
Total reported value
-
$42,995,000
-
Put/Call ratio
-
220%
-
Price per share
-
$2.53
-
Number of holders
-
68
-
Value change
-
+$9,985,055
-
Number of buys
-
40
-
Number of sells
-
36
Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) as of Q2 2019
As of 30 Jun 2019,
ACELRX PHARMACEUTICALS INC - COM (ACRX) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,998,002 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, D. E. Shaw & Co., Inc., Cornerstone Capital, Inc., BRIDGEWAY CAPITAL MANAGEMENT INC, NORTHERN TRUST CORP, WELLS FARGO & COMPANY/MN, and Bank of New York Mellon Corp.
This page lists
68
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.